Summary
Sodium-glucose cotransporter 2 (SGLT2) inhibitors (are novel agents, and this article discusses how these agents can be used in the treatment of patients with diabetes.
- Diabetes Mellitus
- Hyperglycemia/Hypoglycemia
- Endocrinology
- Diabetes & Metabolic Syndrome
- Diabetes Mellitus
- Hyperglycemia/Hypoglycemia
- © 2014 MD Conference Express®
Tools
SGLT2 Inhibitors: A Comprehensive Evaluation of Mechanism of Action, Place in Therapy, and Urogenital Tolerability
Permalink:
Table of contents
Cited By...
- No citing articles found.